GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Other Current Receivables

Acticor Biotech (XPAR:ALACT) Other Current Receivables : €0.26 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Other Current Receivables?

Acticor Biotech's Other Current Receivables for the quarter that ended in Jun. 2023 was €0.26 Mil.

Acticor Biotech's quarterly Other Current Receivables increased from Jun. 2022 (€0.96 Mil) to Dec. 2022 (€1.51 Mil) but then stayed the same from Dec. 2022 (€1.51 Mil) to Jun. 2023 (€0.26 Mil).

Acticor Biotech's annual Other Current Receivables increased from Dec. 2020 (€0.02 Mil) to Dec. 2021 (€1.00 Mil) and increased from Dec. 2021 (€1.00 Mil) to Dec. 2022 (€1.51 Mil).


Acticor Biotech Other Current Receivables Historical Data

The historical data trend for Acticor Biotech's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Other Current Receivables Chart

Acticor Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Receivables
Get a 7-Day Free Trial - 0.23 0.02 1.00 1.51

Acticor Biotech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Current Receivables Get a 7-Day Free Trial Premium Member Only 0.58 1.00 0.96 1.51 0.26

Acticor Biotech Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Acticor Biotech Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Acticor Biotech (XPAR:ALACT) Business Description

Traded in Other Exchanges
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines